Free Trial

TransCode Therapeutics (RNAZ) Institutional Ownership

TransCode Therapeutics logo
$0.54
+0.06 (+12.27%)
(As of 12:50 PM ET)

Institutional Ownership Changes (13F Filings) for TransCode Therapeutics (NASDAQ:RNAZ)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$1.30M
Number of
Institutional Sellers
(last 12 months)
0
Get RNAZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling TransCode Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RNAZ Institutional Buying and Selling by Quarter

TransCode Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/1/2024Sheets Smith Wealth Management50,138$29K0.0%+149.0%0.290%
5/20/2024Virtu Financial LLC55,329$37K0.0%N/A0.836%
11/15/2023Sabby Management LLC250,309$126K0.1%+32.8%12.330%
4/21/2022 K.J. Harrison & Partners Inc19,987$58K0.0%+24.9%0.155%
2/4/2022Redmond Asset Management LLC88,010$224K0.1%N/A0.682%
1/26/2022 K.J. Harrison & Partners Inc16,000$41K0.0%N/A0.124%
11/16/2021ACT Capital L.L.C.50,000$150K0.1%N/A0.387%
11/16/2021National Asset Management Inc.25,000$75K0.0%N/A0.194%
11/16/2021Two Sigma Securities LLC33,314$100K0.0%N/A0.258%
11/12/2021AIGH Capital Management LLC1,270,500$3.80M0.8%N/A9.845%
(Data available from 1/1/2016 forward)

RNAZ Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RNAZ shares?

During the previous two years, the following institutional investors and hedge funds held shares of TransCode Therapeutics shares: Sabby Management LLC ($126K), and Virtu Financial LLC ($37K), Sheets Smith Wealth Management ($29K).Learn more on RNAZ's institutional investors.

Which institutional investors have been buying TransCode Therapeutics stock?

The following institutional investors have purchased TransCode Therapeutics stock in the last 24 months: Sabby Management LLC ($61.87K), Virtu Financial LLC ($55.33K), and Sheets Smith Wealth Management ($30K).

How much institutional buying is happening at TransCode Therapeutics?

Institutional investors have bought a total of 147,201 shares in the last 24 months. This purchase volume represents approximately $1.30M in transactions.



This page (NASDAQ:RNAZ) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners